MedPath

Azithromycin and ceftriaxone verses ceftriaxone alone in a case of prelabour cesarean birth to decrease surgical site infectio

Phase 2
Conditions
Health Condition 1: O860- Infection of obstetric surgical wound
Registration Number
CTRI/2024/04/065067
Lead Sponsor
Dr. Yogesh baburao Munde
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pregnant after 37 weeks with indication breech, previous c-ection,

placenta previa

Exclusion Criteria

Allergy to Azithromycin,contraindications,women in active labour, preterm labour,twins

,Maternal condition

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Reduce surgical site infection <br/ ><br>2.reduce endometritis <br/ ><br>3.improve maternal and neonatal outcomes <br/ ><br>4.safety profileTimepoint: Once weekly
Secondary Outcome Measures
NameTimeMethod
Evidence based practice <br/ ><br>Advancement of knowledgeTimepoint: Evidence based practice according to response <br/ ><br>Advancement of knowledge side effects weekly
© Copyright 2025. All Rights Reserved by MedPath